Skip to main content
SpringerLink
Log in

Peripheral T-lymphocyte subsets in patients treated with Rituximab–Chlorambucil combination therapy for indolent NHL

  • Letter To The Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hainsworth J, Litchy S, Burris H 3rd et al (2003) Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin’s lymphoma. J Clin Oncol 20:4261–4267

    Article  Google Scholar 

  2. Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ (2004) Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin’s lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol 22(23):4711–4716

    Article  PubMed  CAS  Google Scholar 

  3. Marcus R, Imrie K, Belch A et al (2005) CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 105(4):1417–1423

    Article  PubMed  CAS  Google Scholar 

  4. Martinelli G, Laszlo D, Bertolini F et al (2003) Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin’s lymphoma. Br J Haematol 123(2):271–277

    Article  PubMed  CAS  Google Scholar 

  5. Kaplan LD, Lee JY, Ambinder RF et al (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-malignancies consortium trial 010. Blood 106:1538–1543

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Haematology Division, European Institute of Oncology, Milan, Italy

    D. Laszlo, S. Bassi, G. Andreola, A. Agazzi, P. Antoniotti, R. Balzano, P. Mancuso, F. Bertolini & G. Martinelli

Authors
  1. D. Laszlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Bassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Andreola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Agazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Antoniotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Balzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Mancuso
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Bertolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Martinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Laszlo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laszlo, D., Bassi, S., Andreola, G. et al. Peripheral T-lymphocyte subsets in patients treated with Rituximab–Chlorambucil combination therapy for indolent NHL. Ann Hematol 85, 813–814 (2006). https://doi.org/10.1007/s00277-006-0170-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0170-9

Keywords

Search

Navigation